Germany Could Introduce Biosimilar Substitution By Pharmacists In Three Years
Executive Summary
A German bill aims to cut spending on biologics, but new revisions mean that measures on biosimilar substitution are likely to be delayed by three years.
You may also be interested in...
German Guidelines Seek To Boost Biosimilar Uptake
Germany is for the first time to adopt national guidelines on prescribing biologics and biosimilars in a move towards increasing biosimilar uptake.
Germany Sets Direction Of Travel With New Biosimilar Guidelines
Germany is for the first time to adopt national guidelines on prescribing biologics and biosimilars in move towards increasing biosimilar uptake.
German Biosimilar Substitution Law Could Lead To Tendering
A new law in Germany could lead to tendering in the biosimilars space.